Benzodiazepines have been controlled as Class C drugs under the Misuse of Drugs Act 1971 since 1986. The availability of benzodiazepines for legitimate medicinal use is regulated by the Misuse of Drugs Regulations 2001. Most benzodiazepines are regulated under schedule 4, part 1 of the regulations, with the exception of temazepam, flunitrazepam and midazolam which are regulated under schedule 3. Diazepam is also subject to instalment dispensing arrangements.
In 1998, the Advisory Council on the Misuse of Drugs advised the Government that all benzodiazepines should be placed into schedule 3 subject to due consideration of the accompanying prescription and safe custody requirements under the regulations. In response to these concerns, the Government decided that rescheduling of benzodiazepines should be made on a case by case basis, with additional controls on the import, export and possession of all benzodiazepines. These controls were introduced in February 2002.
In 2004, the Advisory Council concluded that the controls for the schedule 4, part 1 benzodiazepines were sufficient, endorsing the Government's response to its earlier recommendation.
The Home Office has not conducted any research or evaluation of possible links between skunk cannabis use and employment rates.